Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1056426.RAV-a-F_YIg00imqrezi_nIUlC7NzWc_bpDJ-7wL326wk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1056426.RAV-a-F_YIg00imqrezi_nIUlC7NzWc_bpDJ-7wL326wk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1056426.RAV-a-F_YIg00imqrezi_nIUlC7NzWc_bpDJ-7wL326wk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1056426.RAV-a-F_YIg00imqrezi_nIUlC7NzWc_bpDJ-7wL326wk130_provenance.
- befree-2016 importedOn "2016-02-19" NP1056426.RAV-a-F_YIg00imqrezi_nIUlC7NzWc_bpDJ-7wL326wk130_provenance.
- NP1056426.RAV-a-F_YIg00imqrezi_nIUlC7NzWc_bpDJ-7wL326wk130_assertion wasGeneratedBy ECO_0000203 NP1056426.RAV-a-F_YIg00imqrezi_nIUlC7NzWc_bpDJ-7wL326wk130_provenance.
- NP1056426.RAV-a-F_YIg00imqrezi_nIUlC7NzWc_bpDJ-7wL326wk130_assertion wasDerivedFrom befree-2016 NP1056426.RAV-a-F_YIg00imqrezi_nIUlC7NzWc_bpDJ-7wL326wk130_provenance.
- NP1056426.RAV-a-F_YIg00imqrezi_nIUlC7NzWc_bpDJ-7wL326wk130_assertion SIO_000772 23445613 NP1056426.RAV-a-F_YIg00imqrezi_nIUlC7NzWc_bpDJ-7wL326wk130_provenance.
- NP1056426.RAV-a-F_YIg00imqrezi_nIUlC7NzWc_bpDJ-7wL326wk130_assertion evidence source_evidence_literature NP1056426.RAV-a-F_YIg00imqrezi_nIUlC7NzWc_bpDJ-7wL326wk130_provenance.
- NP1056426.RAV-a-F_YIg00imqrezi_nIUlC7NzWc_bpDJ-7wL326wk130_assertion description "[These findings create a compelling rationale to determine the in vivo activity of dual PI3K/mTOR inhibitors in combination with JAK inhibitors against myelofibrosis HPCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1056426.RAV-a-F_YIg00imqrezi_nIUlC7NzWc_bpDJ-7wL326wk130_provenance.